Abviva, Inc. (AVVA.OB) is “One to Watch”
Source: http://Blog.QualityStocks.net/?p=11512Posted on Thursday, July 31st, 2008 | In Market Commentary, OTCBB Markets, Small & Micro Cap, Stocks to Watch
Abviva, Inc. (AVVA.OB), a biomedical company that specializes in the development and commercialization of diagnostic and therapeutic products from mammastatin, a growth-regulatory protein that inhibits breast cancer cell growth, was recently noted as a stock to watch. Abviva’s research focuses on developing innovative breast cancer diagnostic and therapeutic products that can benefit individuals throughout the world.
Abviva’s growth strategy is to develop a fully integrated diagnostic and therapeutic business that is sustained by product and services revenues. Additionally, the company plans to commercialize the Mammastatin Serum Assay, which measures a woman’s risk of developing breast cancer, through its wholly owned subsidiary laboratory, as well as develop additional breast cancer therapies through internal and external collaborative research with pharmaceutical, biotechnology and research institutions.
The Mammastatin Serum Assay is currently being studied as a method of providing early detection of breast cancer in women who have no symptoms and to identify women who are at increased risk of developing breast cancer. The company intends to continue to conduct research on mammastatin in order to advance the knowledge and understanding of the biological mechanisms underlying the mammastatin link to breast cancer. When detected early, women can have up to a 98 percent probability of surviving breast cancer.
Let us hear your thoughts: Abviva, Inc. Message Board
Last 5 posts by QualityStocks
- Omnicity Corp. (OMCY.OB) Announces Addition of New Board Member - November 20th, 2009
- Muscle Flex, Inc. (MFLI.PK) Announces Release Time for the BUDDY Tablet Caddy Two-Minute Commercial and Landing Page - November 20th, 2009
- Artfest International, Inc. (ARTS.OB) Announces Revenue Profit Jumps - November 20th, 2009
- Omnicity Corp.’s (OMCY.OB) Recently-Issued Corporate Update - November 20th, 2009
- Soligenix Inc. (SNGX.OB) Taking Steps to Meet Challenges of Vaccine Technology and Biological Warfare - November 20th, 2009
 About QualityStocks (http://QualityStocks.net)
Our name, QualityStocks, emphasizes our commitment to connect subscribers with companies that have huge potential to succeed in the short and long-term future. We believe strong management and vision for the future are crucial for any company to be successful. Timing is everything and we help investors succeed by providing an objective, broad-based view of the SmallCap markets on a daily basis. Please see disclaimer on QualityStocks website: http://disclaimer.qualitystocks.net |
No recommendations, either expressed or implied, are being made to buy, sell, hold or short any of the mentioned stocks. No legal, tax or accounting advice is expressed or implied. Always contact your attorney, CPA, or tax advisor before acting on any legal or tax issues. StraightStocks.com is not responsible for the content, products, or services of any of the advertisers on this site. StraightStocks.com receives compensation from advertisers on this blog. Services and products referred to herein are trademarks, registered trademarks, servicemarks, and/or registered servicemarks of their respective trademark or servicemark owners.